ClinicalTrials.gg
Not yet recruitingNCT07942688Updated Nov 17, 2026

Assessment of AI-Assisted Ultrasound in DDH

An observational study in Developmental Dysplasia of Hip, DDH and Developmental Dysplasia of the Hip, sponsored by The Hospital for Sick Children. Not yet recruiting at 1 site in Canada. Open to participants aged 0 Months to 6 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Primary conditionDevelopmental Dysplasia of the HipRegistry: Hip DislocationReclassifiedWhy we changed it
Registry
Hip Dislocation — the first condition term the registry derived for this study.
ClinicalTrials.gg
Developmental Dysplasia of the Hip
Why
  1. The study's listed conditions name Developmental Dysplasia of the Hip, a narrower term within Hip Dislocation.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by The Hospital for Sick Children · Observational

How we know

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
88
Ages
0 Months to 6 Months
Sex
All
01

Study summary

Developmental dysplasia of the hip (DDH) is a condition in which a baby's hip joint does not develop normally. Ultrasound is commonly used to assess the hips of young infants for DDH, but these examinations usually require trained ultrasound staff and specialist interpretation.

The purpose of this study is to determine whether a handheld ultrasound device combined with artificial intelligence (AI) can be used by non-specialist health care personnel to obtain and assess ultrasound images of infant hips. Infants attending the Baby Hip Clinic at The Hospital for Sick Children (SickKids) will undergo their usual clinical ultrasound as part of their standard care. They will also have an additional research ultrasound performed using the handheld device.

Researchers will compare the research ultrasound with the standard clinical ultrasound. The study will assess the quality of the images obtained using the handheld device and compare the AI-assisted assessment with the diagnosis from the standard ultrasound and assessments made by experienced reviewers. The research ultrasound and AI results will not be used to make treatment decisions for participating infants.

Read the detailed description

Developmental dysplasia of the hip (DDH) describes a spectrum of abnormal development of the infant hip joint. Early identification is important because treatment during infancy is generally effective, whereas delayed diagnosis may lead to more invasive treatment and long-term hip problems. Ultrasound is commonly used to assess infant hips because it allows visualization of both the bony and cartilaginous structures of the developing hip.

Conventional infant hip ultrasound requires appropriate image acquisition and interpretation by trained personnel. This study is evaluating whether a handheld point-of-care ultrasound device combined with artificial intelligence (AI)-assisted image analysis may provide a reliable approach to infant hip assessment when images are obtained by trained non-specialist operators.

This study is being conducted as part of a broader multicentre validation program coordinated by the University of Alberta. The Hospital for Sick Children (SickKids) is participating as a collaborating study site. SickKids is not developing or modifying the AI algorithm as part of this study.

Participants will continue to receive the usual clinical assessment and conventional ultrasound imaging required for their care. The standard-of-care clinical ultrasound and its interpretation will remain the basis for clinical diagnosis and treatment decisions.

During the same clinical visit, an additional research ultrasound examination will be performed using the Exo Iris handheld ultrasound system. Research scans will be performed by trained study personnel who are not required to be specialist sonographers or radiologists. The research examination is being conducted for study purposes only and is not intended to replace the participant's standard clinical ultrasound.

The handheld ultrasound images will be processed using the study AI system to generate an AI-assisted assessment of the infant hip. The research images and AI-generated information will not be used to guide the participant's clinical care. Treating clinicians will continue to make all diagnostic and treatment decisions using the standard clinical information available to them.

The investigators seek to assess the accuracy of this AI -assisted hip ultrasound probe, comparing it to conventional 2D ultrasound. The investigators also seek to assess the effectiveness of this device when it is operated by a non-specialist medical personnel (the 'novice user'), one who does not normally perform infant hip scanning. The broader ramifications of this study could help confirm whether AI-assisted hip ultrasound could be used to screen infant hips in regions where there is minimal access to ultrasound due to a lack of trained personnel and specialist equipment.

02

Conditions studied

  • Developmental Dysplasia of Hip
  • DDH
  • Developmental Dysplasia of the Hip
  • Developmental Dysplasia of the Hip (DDH)
  • Hip Dysplasia

Browse trials for

Keywords

  • Ultrasound
  • Hip Dysplasia
  • Artificial Intelligence
  • Exo Iris Probe
  • MEDO Hip App
  • Paediatric Orthopaedics
  • Infant
  • developmental dysplasia of the hip
  • Standard of Care
  • AI-Assisted Ultrasound
03

In context

Developmental Dysplasia of the Hip Reclassified

61 studies on the registry are indexed under Developmental Dysplasia of the Hip; 19 are open to participants now.

This study's planned enrollment of 88 is above the median of 74 across 22 observational studies indexed under Developmental Dysplasia of the Hip.

Browse Developmental Dysplasia of the Hip studies →

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 82 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Compared within Developmental Dysplasia of the Hip, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hip Dislocation. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
0 Months to 6 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Infants aged 0 to 6 months referred to the Orthopaedic Baby Hip Clinic at The Hospital for Sick Children (SickKids) for clinical assessment of possible or confirmed developmental dysplasia of the hip (DDH). Infants undergoing clinically indicated standard-of-care hip ultrasound assessment as part of their routine Baby Hip Clinic visit will be invited to participate in this additional research ultrasound.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants referred to the SickKids Orthopaedic Baby Hip Clinic for possible or confirmed DDH.
  • Infants aged 0-6 months.
  • Parent/guardian willing and able to provide consent on behalf of the infant.

Exclusion criteria

Exclusion Criteria:

  • Infants with known or suspected neuromuscular, collagen, chromosomal or lower-extremity congenital abnormalities or syndromic-associated hip abnormalities.
  • Infants that have already started treatment.
  • Parent/guardian not willing and able to provide consent on behalf of the infant.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
88 participants (estimated)
Patient registry
No

Groups and cohorts

  • Infants Undergoing Hip Assessment for DDH

    Infants undergoing clinical assessment for developmental dysplasia of the hip (DDH) at the Baby Hip Clinic. Participants will receive their standard clinical assessment and conventional hip ultrasound, as applicable, and will also undergo an additional research ultrasound using the handheld Exo Iris device with AI-assisted analysis. Research ultrasound and AI findings will be compared with standard clinical imaging and expert assessment and will not be used to guide clinical care.

    Device: Handheld Point-of-Care Hip Ultrasound with AI-Assisted Analysis

Interventions

  • DeviceHandheld Point-of-Care Hip Ultrasound with AI-Assisted Analysis

    Participants will undergo an additional research hip ultrasound using a handheld point-of-care ultrasound device. The research scan will be performed by a lightly trained study personnel (ex. Nurse practitioner or orthopaedic surgery fellow) and will be separate from the participant's standard clinical ultrasound examination. Images obtained during the research scan will be analyzed using an artificial intelligence-assisted system designed to support assessment of infant hip anatomy and developmental dysplasia of the hip (DDH). The research images and AI-generated assessments will be compared with standard clinical ultrasound findings and expert review. The research ultrasound and AI results will not be used to make clinical diagnoses or treatment decisions and will not replace standard-of-care imaging.

    Also known as: Exo Iris, Medo Hip App

06

What researchers measure

Primary outcomes

  1. Agreement in Alpha Angle Measurements

    Agreement between alpha angle measurements obtained from the AI-assisted research ultrasound and measurements obtained from conventional 2D ultrasound will be assessed using an absolute-agreement intraclass correlation coefficient (ICC). Agreement will also be evaluated using Bland-Altman analysis, including mean difference (bias) and 95% limits of agreement.

    Time frame: Day 1

Secondary outcomes

  1. Agreement in Femoral Head Coverage

    Percentage femoral head coverage measured using the AI-assisted research ultrasound will be compared with femoral head coverage measured from the conventional 2D ultrasound assessment to evaluate agreement between the two imaging methods.

    Time frame: Day 1

  2. Agreement in DDH Diagnostic Classification

    Agreement between the AI-assisted ultrasound classification and the standard-of-care diagnosis will be assessed. Hips will be classified as normal, immature/borderline, or dysplastic based on ultrasound findings. Agreement will be summarized using percentage agreement and Randolph's kappa.

    Time frame: Day 1

  3. Diagnostic Image Quality

    De-identified AI-assisted ultrasound images will be reviewed by expert reviewers to determine whether the images are of sufficient diagnostic quality for clinical decision-making. Image quality will be scored using the 10-point Hareendranathan ultrasound image quality scoring system.

    Time frame: Day 1

07

Study locations

1 site
08

References and documents

Publications

  • Hareendranathan AR, Chahal B, Ghasseminia S, Zonoobi D, Jaremko JL. Impact of scan quality on AI assessment of hip dysplasia ultrasound. J Ultrasound. 2022 Jun;25(2):145-153. doi: 10.1007/s40477-021-00560-4. Epub 2021 Mar 5. PubMed 33675031 ↗
  • Jaremko JL, Hareendranathan A, Bolouri SES, Frey RF, Dulai S, Bailey AL. AI aided workflow for hip dysplasia screening using ultrasound in primary care clinics. Sci Rep. 2023 Jun 7;13(1):9224. doi: 10.1038/s41598-023-35603-9. PubMed 37286559 ↗
  • Morin C, Zouaoui S, Delvalle-Fayada A, Delforge PM, Leclet H. Ultrasound assessment of the acetabulum in the infant hip. Acta Orthop Belg. 1999 Sep;65(3):261-5. PubMed 10546348 ↗
  • Roovers EA, Boere-Boonekamp MM, Geertsma TS, Zielhuis GA, Kerkhoff AH. Ultrasonographic screening for developmental dysplasia of the hip in infants. Reproducibility of assessments made by radiographers. J Bone Joint Surg Br. 2003 Jul;85(5):726-30. PubMed 12892198 ↗
  • Simon EA, Saur F, Buerge M, Glaab R, Roos M, Kohler G. Inter-observer agreement of ultrasonographic measurement of alpha and beta angles and the final type classification based on the Graf method. Swiss Med Wkly. 2004 Nov 13;134(45-46):671-7. doi: 10.4414/smw.2004.10764. PubMed 15611889 ↗
  • Morin C, Harcke HT, MacEwen GD. The infant hip: real-time US assessment of acetabular development. Radiology. 1985 Dec;157(3):673-7. doi: 10.1148/radiology.157.3.3903854. PubMed 3903854 ↗
  • Graf R. Fundamentals of sonographic diagnosis of infant hip dysplasia. J Pediatr Orthop. 1984 Nov;4(6):735-40. doi: 10.1097/01241398-198411000-00015. PubMed 6392336 ↗
  • Harcke HT, Clarke NM, Lee MS, Borns PF, MacEwen GD. Examination of the infant hip with real-time ultrasonography. J Ultrasound Med. 1984 Mar;3(3):131-7. doi: 10.7863/jum.1984.3.3.131. PubMed 6726860 ↗
  • Shorter D, Hong T, Osborn DA. Screening programmes for developmental dysplasia of the hip in newborn infants. Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD004595. doi: 10.1002/14651858.CD004595.pub2. PubMed 21901691 ↗
  • Holen KJ, Tegnander A, Bredland T, Johansen OJ, Saether OD, Eik-Nes SH, Terjesen T. Universal or selective screening of the neonatal hip using ultrasound? A prospective, randomised trial of 15,529 newborn infants. J Bone Joint Surg Br. 2002 Aug;84(6):886-90. doi: 10.1302/0301-620x.84b6.12093. PubMed 12211684 ↗
  • Gwynne Jones DP, Vane AG, Coulter G, Herbison P, Dunbar JD. Ultrasound measurements in the management of unstable hips treated with the pavlik harness: reliability and correlation with outcome. J Pediatr Orthop. 2006 Nov-Dec;26(6):818-22. doi: 10.1097/01.bpo.0000234999.61595.ec. PubMed 17065955 ↗
  • Bache CE, Clegg J, Herron M. Risk factors for developmental dysplasia of the hip: ultrasonographic findings in the neonatal period. J Pediatr Orthop B. 2002 Jul;11(3):212-8. doi: 10.1097/00009957-200207000-00004. PubMed 12089497 ↗
  • Cashman JP, Round J, Taylor G, Clarke NM. The natural history of developmental dysplasia of the hip after early supervised treatment in the Pavlik harness. A prospective, longitudinal follow-up. J Bone Joint Surg Br. 2002 Apr;84(3):418-25. doi: 10.1302/0301-620x.84b3.12230. PubMed 12002504 ↗
  • Storer SK, Skaggs DL. Developmental dysplasia of the hip. Am Fam Physician. 2006 Oct 15;74(8):1310-6. PubMed 17087424 ↗
  • Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI. Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99. J Bone Joint Surg Br. 2001 May;83(4):579-86. doi: 10.1302/0301-620x.83b4.11223. PubMed 11380136 ↗

Individual participant data

Plan to share: No — There is currently no plan to share individual participant data (IPD) from this trial. Following completion of local study procedures, authorized SickKids study team members will upload coded research data and de-identified research ultrasound images to the University of Alberta secure REDCap. The University of Alberta will retain only the transferred data that is provided by the SickKids team and only transferred dataset that is required to complete the approved analyses.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 1, 2026
First posted
Nov 17, 2026
StartEst.
Nov 2026
Primary completionEst.
May 2027
CompletionEst.
Jun 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942688
Responsible party
Richard Gardner (Staff Orthopaedic Surgeon, Division of Orthopaedic Surgery, The Hospital for Sick Children, The Hospital for Sick Children) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Richard Gardner
Contact
richard.gardner@sickkids.ca
416-813-7654 ext. 415535
Olivia Garisto
Contact
olivia.garisto@sickkids.ca
Richard Gardner
principal investigator · The Hospital for Sick Children

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion